JASON ERIKSEN to Amyloid Precursor Protein Secretases
This is a "connection" page, showing publications JASON ERIKSEN has written about Amyloid Precursor Protein Secretases.
Connection Strength
0.178
-
Substrate-targeting gamma-secretase modulators. Nature. 2008 Jun 12; 453(7197):925-9.
Score: 0.078
-
NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest. 2003 Aug; 112(3):440-9.
Score: 0.056
-
Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med. 2005 May; 11(5):545-50.
Score: 0.016
-
Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J Biol Chem. 2003 Aug 22; 278(34):31831-7.
Score: 0.014
-
Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. J Biol Chem. 2003 Aug 15; 278(33):30748-54.
Score: 0.014